相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection
Matthew T. Kitson et al.
JOURNAL OF HEPATOLOGY (2013)
Maximizing Opportunities and Avoiding Mistakes in Triple Therapy for Hepatitis C Virus
A. Sidney Barritt et al.
GASTROENTEROLOGY (2012)
Identification of Type I and Type II Interferon-Induced Effectors Controlling Hepatitis C Virus Replication
Philippe Metz et al.
HEPATOLOGY (2012)
25-hydroxyvitamin D3 suppresses hepatitis C virus production
Takuya Matsumura et al.
HEPATOLOGY (2012)
D-livering the message: The importance of vitamin D status in chronic liver disease
Matthew T. Kitson et al.
JOURNAL OF HEPATOLOGY (2012)
A Genetic Validation Study Reveals a Role of Vitamin D Metabolism in the Response to Interferon-Alfa-Based Therapy of Chronic Hepatitis C
Christian M. Lange et al.
PLOS ONE (2012)
Evaluation of Early Null Response to Pegylated Interferon and Ribavirin as a Predictor of Therapeutic Nonresponse in Patients Undergoing Treatment for Chronic Hepatitis C
Nancy Reau et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Response-Guided Peg-Interferon Plus Ribavirin Treatment Duration in Chronic Hepatitis C: Meta-Analyses of Randomized, Controlled Trials and Implications for the Future
Vincent Di Martino et al.
HEPATOLOGY (2011)
Vitamin D: An Innate Antiviral Agent Suppressing Hepatitis C Virus in Human Hepatocytes
Meital Gal-Tanamy et al.
HEPATOLOGY (2011)
Complementary Role of Vitamin D Deficiency and the Interleukin-28B rs12979860 C/T Polymorphism in Predicting Antiviral Response in Chronic Hepatitis C
Davide Bitetto et al.
HEPATOLOGY (2011)
Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infection
Michael W. Fried et al.
JOURNAL OF HEPATOLOGY (2011)
Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy
Christian Markus Lange et al.
JOURNAL OF HEPATOLOGY (2011)
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
Kenneth E. Sherman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Bruce R. Bacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Retreatment of HCV Infection
Stefan Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naive patients
Saif Abu-Mouch et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Vitamin D: modulator of the immune system
Femke Baeke et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Low Vitamin D Serum Level Is Related to Severe Fibrosis and Low Responsiveness to Interferon-Based Therapy in Genotype 1 Chronic Hepatitis C
Salvatore Petta et al.
HEPATOLOGY (2010)
Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
Paul Y. Kwo et al.
LANCET (2010)
Optimal length of antiviral therapy in patients with hepatitis C virus genotypes 2 and 3: a meta-analysis
Serena Slavenburg et al.
ANTIVIRAL THERAPY (2009)
Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial
Ming-Lung Yu et al.
HEPATOLOGY (2008)
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
Joseph F. Perz et al.
JOURNAL OF HEPATOLOGY (2006)
Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C
M. Martinot-Peignoux et al.
JOURNAL OF VIRAL HEPATITIS (2006)
VX-950, a novel hepatitis C virus (HCV) NS34A protease inhibitor, exhibits potent antiviral activities in HCV replicon cells
K Lin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Vitamin D and calcium deficits predispose for multiple chronic diseases
M Peterlik et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2005)
Global epidemiology of hepatitis C virus infection
CW Shepard et al.
LANCET INFECTIOUS DISEASES (2005)
分享论文
